Open-label study of the efficacy, safety, and durability of peanut sublingual immunotherapy in peanut-allergic children.

The Journal of allergy and clinical immunology(2023)

引用 8|浏览19
暂无评分
摘要
In this open-label, prospective study, peanut SLIT was safe and induced clinically significant desensitization in most of the children, lasting more than 17 weeks after discontinuation of therapy.
更多
查看译文
关键词
IgE,IgG4,Peanut allergy,SLIT,basophil activation test,desensitization,food allergy,sublingual immunotherapy,sustained unresponsiveness
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要